Percutaneous Options for Treatment of Mitral and Tricuspid Regurgitation

Anene Ukaigwe, MD, details the impact of mitral and tricuspid valve regurgitation, while providing an overview of percutaneous therapies and devices in clinical trials.

Created by

University Hospitals

Related Presenters

Anene Ukaigwe, MD

Anene Ukaigwe, MD

Interventional Cardiologist, University Hospitals Harrington Heart & Vascular Institute

Expertise: Coronary Artery Disease (CAD), Hypertrophic Cardiomyopathy, Left Atrial Appendage Occlusion, Mitral Valve Disease, Tricuspid Valve Disease, and Valvular Heart Disease

View full profile